Blood Cancer J. 2012 Jan;2(1):e49. doi: 10.1038/bcj.2011.48. Epub 2012 Jan 13.
Although iron overload is clinically significant, only limited data have been published on iron overload in haematological diseases. We investigated cardiac and liver iron accumulation by magnetic resonance imaging (MRI) in a cohort of 87 subjects who did not receive chelation, including 59 haematological patients. M-HIC (MRI-based hepatic iron concentration, normal values <36 μmol/g) is a non-invasive, liver biopsy-calibrated method to analyse iron concentration. This method, calibrated to R2 (transverse relaxation rate), was used as a reference standard (M-HIC(R2)). Transfusions and ferritin were evaluated. Mean M-HIC(R2) and cardiac R() of all patients were 142 μmol/g (95% CI, 114-170) and 36.4 1/s (95% CI, 34.2-38.5), respectively. M-HIC(R2) was higher in haematological patients than in patients with chronic liver disease or normal controls (P<0.001). Clearly elevated cardiac R2() was found in two myelodysplastic syndrome (MDS) patients with severe liver iron overload. A poor correlation was found between liver and cardiac iron (n=82, r=0.322, P=0.003), in contrast to a stronger correlation in MDS (n=7, r=0.905, P=0.005). In addition to transfusions, MDS seemed to be an independent factor in iron accumulation. In conclusion, the risk for cardiac iron overload in haematological diseases other than MDS is very low, despite the frequently found liver iron overload.
虽然铁过载在临床上很重要,但关于血液系统疾病中铁过载的资料有限。我们通过磁共振成像(MRI)调查了未接受螯合治疗的 87 名受试者(包括 59 名血液系统疾病患者)的心脏和肝脏铁积累。M-HIC(基于 MRI 的肝脏铁浓度,正常值<36μmol/g)是一种非侵入性的、与肝活检相校准的分析铁浓度的方法。该方法用 R2(横向弛豫率)进行校准,作为参考标准(M-HIC(R2))。我们评估了输血和铁蛋白。所有患者的平均 M-HIC(R2)和心脏 R()分别为 142μmol/g(95%CI,114-170)和 36.4 1/s(95%CI,34.2-38.5)。血液系统疾病患者的 M-HIC(R2)高于慢性肝病患者或正常对照组(P<0.001)。两名骨髓增生异常综合征(MDS)患者的心脏 R2()明显升高,且这两名患者均伴有严重的肝脏铁过载。在 82 名患者中发现肝脏和心脏铁之间的相关性较差(n=82,r=0.322,P=0.003),而在 7 名 MDS 患者中相关性较强(n=7,r=0.905,P=0.005)。除了输血外,MDS 似乎也是铁积累的一个独立因素。总之,除 MDS 外,血液系统疾病中心脏铁过载的风险非常低,尽管经常发现肝脏铁过载。